Showing results (121-130 of 156) with videos related to

Sort By:
Pageof 16
Biochimica Et Biophysica Acta. Molecular Basis of Disease|August 10, 2025
Synergistic effects of oncogene inhibition and pyruvate dehydrogenase kinase blockade in resistant NSCLC cellsLuisa Amato, Caterina De Rosa, Daniela Omodei, et al.
Diagnostics (Basel, Switzerland)|May 27, 2023
CARdioimaging in Lung Cancer PatiEnts Undergoing Radical RadioTherapy: CARE-RT TrialValerio Nardone, Maria Paola Belfiore, Marco De Chiara, et al.
The Oncologist|February 20, 2024
Atezolizumab Plus Carboplatin and Etoposide in Patients with Untreated Extensive-Stage Small-Cell Lung Cancer: Interim Results of the MAURIS Phase IIIb TrialEmilio Bria, Floriana Morgillo, Marina Chiara Garassino, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 30, 2018
Nivolumab in never-smokers with advanced squamous non-small cell lung cancer: Results from the Italian cohort of an expanded access programMarina Chiara Garassino, Lucio Crinò, Annamaria Catino, et al.
Therapeutic Advances in Medical Oncology|May 13, 2022
Comprehensive genome profiling by next generation sequencing of circulating tumor DNA in solid tumors: a single academic institution experienceVincenza Caputo, Vincenzo De Falco, Anna Ventriglia, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 29, 2022
Anti-tumor activity of cetuximab plus avelumab in non-small cell lung cancer patients involves innate immunity activation: findings from the CAVE-Lung trialCarminia Maria Della Corte, Morena Fasano, Vincenza Ciaramella, et al.
Translational Oncology|April 5, 2026
Proof-of-concept study of clinical use of blood-based MAVS biosensor in predicting immunotherapy response in SCLC patientsLuisa Amato, Ines Tavoletta, Caterina De Rosa, et al.
Cancers|September 28, 2024
Immune-Cell-Derived Exosomes as a Potential Novel Tool to Investigate Immune Responsiveness in SCLC Patients: A Proof-of-Concept StudyLuisa Amato, Caterina De Rosa, Viviana De Rosa, et al.
Clinical Lung Cancer|July 30, 2025
The Italian Mauris Phase IIIb Trial of Atezolizumab Plus Carboplatin and Etoposide for Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer: 3-Year End-of-Study ResultsFloriana Morgillo, Ester Del Signore, Emilio Bria, et al.
International Journal of Molecular Sciences|July 29, 2025
Effect of IL-1β on NSCLC-Derived Small Extracellular Vesicles as Actors in Mediating Cancer Progression and Evading Immune SystemHamid Heydari Sheikhhossein, Luisa Amato, Viviana De Rosa, et al.
Pageof 16